A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

NCT02345057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

365

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: CS-3150
DRUG: placebo

Sponsor

Daiichi Sankyo